Chou, C.-Y.; Cheng, W.-F.; Chen, M.-Y.; Lin, H.; Ho, C.-M.; Hung, Y.-C.; Huang, L.-W.; Wang, P.-H.; Yu, M.-H.; Huang, Y.-F.
Predicting Long-Term Prognoses and Grading Platinum Sensitivity Using a Novel Progression-Free Interval Criterion in Ovarian Clear Cell Carcinoma: A Multi-Institutional Cohort Study. Cancers 2022, 14, 1746.
https://doi.org/10.3390/cancers14071746
AMA Style
Chou C-Y, Cheng W-F, Chen M-Y, Lin H, Ho C-M, Hung Y-C, Huang L-W, Wang P-H, Yu M-H, Huang Y-F.
Predicting Long-Term Prognoses and Grading Platinum Sensitivity Using a Novel Progression-Free Interval Criterion in Ovarian Clear Cell Carcinoma: A Multi-Institutional Cohort Study. Cancers. 2022; 14(7):1746.
https://doi.org/10.3390/cancers14071746
Chicago/Turabian Style
Chou, Cheng-Yang, Wen-Fang Cheng, Min-Yu Chen, Hao Lin, Chih-Ming Ho, Yao-Ching Hung, Lee-Wen Huang, Po-Hui Wang, Mu-Hsien Yu, and Yu-Fang Huang.
2022. "Predicting Long-Term Prognoses and Grading Platinum Sensitivity Using a Novel Progression-Free Interval Criterion in Ovarian Clear Cell Carcinoma: A Multi-Institutional Cohort Study" Cancers 14, no. 7: 1746.
https://doi.org/10.3390/cancers14071746
APA Style
Chou, C.-Y., Cheng, W.-F., Chen, M.-Y., Lin, H., Ho, C.-M., Hung, Y.-C., Huang, L.-W., Wang, P.-H., Yu, M.-H., & Huang, Y.-F.
(2022). Predicting Long-Term Prognoses and Grading Platinum Sensitivity Using a Novel Progression-Free Interval Criterion in Ovarian Clear Cell Carcinoma: A Multi-Institutional Cohort Study. Cancers, 14(7), 1746.
https://doi.org/10.3390/cancers14071746
